Hong Kong IVD Registration

IVD registration in Hong Kong, also known as “Listing”, is voluntary under the Medical Device Administrative Control System (MDACS).

Managed by the Medical Device Division (MDD) of the Department of Health, MDACS facilitates pre-market control of medical devices, including IVDs.

Though voluntary, IVD listing is strongly encouraged for procurement purposes by public hospitals, clinics, and the Hospital Authority.

Hong Kong IVD Registration
Voluntary registration in the Hong Kong market

How to List an IVD in Hong Kong

To list an IVD under MDACS, the manufacturer (foreign or local) must appoint a Local Responsible Person (LRP) and submit a registration application to the MDD with:

Class I IVDs: Filing/notification with technical documentation is sufficient. Once approved, the product receives a Certificate of Filing with indefinite validity unless modified.
Class II & III IVDs: Require a full registration process, including type testing, either a China Clinical Trial or a Clinical Evaluation Report (CER), and QMS assessment.

How to List an IVD in Hong Kong

To list an IVD under MDACS, the manufacturer (foreign or local) must appoint a Local Responsible Person (LRP) and submit a registration application to the MDD with:

Scientific and medical writing including Clinical Evaluation Reports (CERs) and Performance Evaluation Reports (PERs)
Essential Principles Conformity Checklist (TR-005) for IVDs
Risk analysis and performance evaluation data
Instructions for use (IFU), labeling, and specimen collection details
Quality management system (QMS) certificate (e.g., ISO 13485)

IVD Conformity Assessment Requirements

The IVD must conform to the Technical Reference TR-005, which outlines the Essential Principles of Safety and Performance specific to IVDs. Depending on the classification, the MDD may request clinical performance data and additional documentation during review. The Conformity Assessment Body (CAB) evaluates whether the product meets these standards.

IVD Risk Classification in Hong Kong

Under the MDACS, Hong Kong applies the IMDRF IVD classification system, dividing IVDs into Classes A, B, C, and D based on risk. Only Classes B, C, and D are eligible for listing under the MDACS, similar to the classification of medical devices in Classes II, III and IV.

The level of regulatory control increases as the risk classification of the devices rises, aligning with international guidelines to ensure compliance during the device registration process.

Class A: Lowest risk – not eligible for listing
Class B-D: Medium to high risk – eligible for voluntary listing.

Why List Your IVD Device in Hong Kong?

Since 1 November 2024, all Department of Health tenders require an MDACS Listing Number or Application Number for IVD devices.
MDACS listing increases credibility and access to public procurement, including Hospital Authority and public clinics.
A listed IVD device gains competitive advantage and is preferred in tenders over unlisted alternatives.
Registration supports Greater Bay Area (GBA) access and may support participation in the GBA Connect Scheme for urgently needed diagnostics in designated hospitals in Guangdong Province, including Shenzhen and Zhuhai.

China Greater Bay Area Connect Scheme for IVDs

The GBA Connect Scheme allows IVD devices without prior approval in China but with reference-country listings to be used in designated GBA hospitals. As of February 2025, 45 hospitals are included in the scheme. Hong Kong listing is a key stepping stone for manufacturers targeting the GBA and mainland China markets.

Our Hong Kong IVD Listing Services

We offer end-to-end support for IVD registration or listing in Hong Kong:

IVD risk classification and listing strategy
Guidance on best regulatory pathways
Labeling and UDI compliance support
Handling of Supplementary Notices, renewals, and post-listing changes.
Preparation and submission of:
  • Hong Kong MDACS Listing
  • GBA Connect applications
  • Expedited approval routes where eligible

Request a Proposal to List Your IVDs in Hong Kong

Let Cisema help turn your plans into reality.

Request Proposal

Useful Articles

View More

Cisema Launches a Redesigned Website

Learn about Cisema’s redesigned website with faster performance, clearer navigation and expanded Asia Pacific coverage.

May 6, 2026
Cisema Launches a Redesigned Website
Cisema Logo: Navigating Regulation, Empowering Innovation

China Medical Device and IVD Registration FAQs: What Foreign Manufacturers Need to Know About NMPA Requirements

Get answers to common China medical device and IVD registration questions, from NMPA classification rules to testing and renewal requirements.

April 23, 2026
China Medical Device and IVD Registration FAQs: What Foreign Manufacturers Need to Know About NMPA Requirements
China Medical Device and IVD Registration FAQs: What Foreign Manufacturers Need to Know About NMPA Requirements

China IVD Risk Classification Explained: How NMPA Class Shapes Registration Pathways

Learn how China IVD risk classification works under NMPA rules and see common compliance pitfalls to avoid.

April 23, 2026
China IVD Risk Classification Explained: How NMPA Class Shapes Registration Pathways
China IVD Risk Classification Explained: How NMPA Class Shapes Registration Pathways

GBA Connect Scheme: Using Real World Data to Support China NMPA Approval

Discover how leveraging Real World Data generated in the Greater Bay Area can accelerate market entry for medical products in China.

April 23, 2026
GBA Connect Scheme: Using Real World Data to Support China NMPA Approval
GBA Connect Scheme: Using Real World Data to Support China NMPA Approval
Previous
Previous

Explore Related Services

Whether you’re just starting out or are a blue-chip, access our wide range of services and outsourcing solutions to help your business thrive.

Hong Kong Local 
Responsible Person

We are your authorized representative in Hong Kong, and fulfill your listings as well as ensuring compliance with PMS requirements.

Learn more

Hong Kong Medical Device Listing

We’re with you every step of the way in getting your medical device listed in Hong Kong. From risk classification to navigating all regulatory requirements, we streamline the process to save you time and hassle.

Learn more

China Medical Device Registration

We guide you through every step of the China medical device registration and filing process. We take care of compliance with NMPA requirements, advising you on the optimal market entry pathway, and helping you through the whole process.

Learn more

Drug Device Combination Products

We assist with the classification, registration, and compliance of combination products in China, whether drug or device led.

Learn more

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, we have a variety of solutions to meet your needs.

Learn more

China Clinical Trials

You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China.Our clinical research team will advise you, prepare the study protocol and assist setting up the clinical trial in China.

Learn more

Medical Device PMS & Vigilance

The NMPA is placing greater focus on Post-Market Surveillance (PMS) such as more in-market sampling inspections and regular standard changes.Our specialist PMS team means you stay up to date with the many aspects of compliance.

Learn more

NMPA Type Testing

Our on-site test engineers coordinate and supervise type tests of your medical devices in NMPA-accredited laboratories.

Learn more

Latest Insights

View More

MFDS Issues 2025 Korea Medical Device Regulatory Update Report

Summary of 2025 MFDS trends covering medical device approvals, import dynamics, and the shift toward AI and software-based regulation.

June 2, 2026
MFDS Issues 2025 Korea Medical Device Regulatory Update Report

Hong Kong Expands Medical Device Listing Scope for Injectable Dermal Fillers

The updated GN-00 guidance reduces classification uncertainty and creates clearer MDACS pathways for injectable dermal fillers in Hong Kong.

May 29, 2026
Hong Kong Expands Medical Device Listing Scope for Injectable Dermal Fillers
Stock photo of a Chinese woman seated in a modern medical aesthetics clinic just seconds before receiving dermal filler treatment

Hong Kong Launches Primary Evaluation Phase 1 for NDAs

Hong Kong introduces Primary Evaluation Phase 1 for NDAs, requiring pathway selection across 3 routes and reshaping drug registration strategy.

May 6, 2026
Hong Kong Launches Primary Evaluation Phase 1 for NDAs
A single Asian scientist in their 30s wearing a lab coat, safety glasses, and nitrile gloves seated at a tidy bench in a modern pharmaceutical laboratory in Hong Kong, calmly reviewing a few printed documents while referencing a simple laptop screen

Hong Kong Clarifies Classification of Injectable Products

Hong Kong classifies classifcation of injectable products, impacting medical aesthetics and borderline products.

May 13, 2026
Hong Kong Clarifies Classification of Injectable Products
Minimalist, well-lit medical aesthetics clinic in Hong Kong. An Asian female doctor in a simple white coat and disposable gloves sits beside a female patient, holding a single unbranded prefilled syringe at chest level.

Hong Kong to Regulate Medical Gases as Pharmaceutical Products from June 2026

Learn the registration requirements, scope, and compliance steps as Hong Kong regulates medical gases as pharmaceutical products.

April 23, 2026
Hong Kong to Regulate Medical Gases as Pharmaceutical Products from June 2026

China NMPA Issues 2026 Medical Device Industry Standards Development and Revision Plan

China’s National Medical Products Administration has issued its 2026 medical device standards plan, introducing 80+ new and revised standards

April 23, 2026
China NMPA Issues 2026 Medical Device Industry Standards Development and Revision Plan
Previous
Previous

Get in Touch with Our Life Sciences Team

And discover how we can support you in achieving approval in the voluntary system for your in vitro diagnostic in Hong Kong.

Request Proposal